What is the recommended first‑line antihypertensive regimen for an adult with hypertension, considering age, race, comorbid conditions, and contraindications?

First-Line Antihypertensive Regimen Selection

For most adults with hypertension, initial therapy should be a thiazide-type diuretic, ACE inhibitor/ARB, or calcium channel blocker, with specific selection based on race and comorbidities—particularly, Black patients without heart failure or chronic kidney disease should start with a thiazide-type diuretic or calcium channel blocker. 1, 2

General Population Approach

Non-Black Patients

• Start with low-dose ACE inhibitor or ARB as first-line monotherapy 3, 4
• If blood pressure remains uncontrolled, add a dihydropyridine calcium channel blocker (DHP-CCB) 3
• Increase to full dose before adding additional agents 3
• Third-line: add a thiazide or thiazide-like diuretic 3, 4

Black Patients Without Heart Failure or CKD

• Initial treatment must include either a thiazide-type diuretic OR a calcium channel blocker 1, 2, 5
• These agents are significantly more effective than ACE inhibitors or ARBs as monotherapy in Black patients 1, 6
• Preferred initial regimen: low-dose ARB combined with DHP-CCB or thiazide/thiazide-like diuretic 3, 6
• ACE inhibitors like benazepril are less effective as monotherapy in this population 6
• Black patients have 1.3-times greater risk of nonfatal stroke, 1.8-times greater risk of fatal stroke, and 4.2-times greater risk of end-stage renal disease, making appropriate initial therapy critical 1, 2

Dosing Specifications

Thiazide Diuretics

• Hydrochlorothiazide: 25-50 mg daily for optimal blood pressure control in Black patients 6
• Chlorthalidone: 12.5-25 mg daily for endpoint protection 2
• Lower doses are either unproven or less effective in clinical outcome trials 2

Combination Therapy Requirements

• Two or more antihypertensive medications are required to achieve BP target <130/80 mmHg in most adults, especially Black adults 1, 2, 5
• Single-pill combinations improve adherence and are particularly effective when including either a diuretic or CCB 6
• Consider monotherapy only in low-risk grade 1 hypertension, patients aged >80 years, or frail patients 3

Age-Specific Considerations

Adults Under 65 Years

• Target blood pressure: <130/80 mmHg 3, 4
• Most will require combination therapy to achieve target 1

Adults 65 Years and Older

• Target systolic blood pressure: <130 mmHg 4
• May consider monotherapy if frail 3
• Individualize based on frailty status 3

Comorbidity-Driven Selection

Diabetes Mellitus

• Target BP: <130/80 mmHg 7
• Black patients with diabetes: thiazide-type diuretic or CCB remains first-line 1, 2
• ACE inhibitors or ARBs provide additional renal protection but should be combined with diuretic or CCB in Black patients 2

Chronic Kidney Disease

• Target BP: <130/80 mmHg 7
• ACE inhibitors or ARBs are indicated as part of the regimen despite reduced efficacy as monotherapy in Black patients 6
• Combination with CCB or thiazide diuretic produces similar BP lowering across all racial groups 1, 6

Heart Failure

• ACE inhibitors or ARBs become first-line regardless of race 1
• Beta-blockers are indicated in this specific setting 7

Critical Safety Considerations

Race-Specific Adverse Effects

• Black patients have greater risk of angioedema with ACE inhibitors compared to other racial groups 6
• This represents an important safety consideration when selecting renin-angiotensin system inhibitors 6

Combination Therapy Cautions

• Use initial combined therapy cautiously in patients at risk of orthostatic hypotension 7
• Avoid combining ACE inhibitors with ARBs—this combination is not recommended 1

Treatment Escalation Algorithm

Stage 1 Hypertension (140-159/90-99 mmHg)

• High-risk patients (CVD, CKD, diabetes, organ damage): start drug treatment immediately 3
• Low-moderate risk patients: start lifestyle interventions, add drug treatment if BP remains elevated after 3-6 months 3

Stage 2 Hypertension (≥160/100 mmHg)

• Start drug treatment immediately with two-drug combination for most patients 3, 7
• Usual combination: thiazide-type diuretic plus ACE inhibitor, ARB, or CCB 7

Resistant Hypertension (Uncontrolled on 3 Drugs)

• Add spironolactone as fourth-line agent 3
• Alternatives if spironolactone not tolerated: amiloride, doxazosin, eplerenone, clonidine, or beta-blocker 3

Monitoring Timeline

• Achieve target blood pressure within 3 months of initiating therapy 3, 6
• Minimum BP reduction goal: 20/10 mmHg even if target not fully achieved 3
• Use home BP monitoring to confirm office readings (home BP ≥135/85 mmHg indicates hypertension) 3

Common Pitfalls to Avoid

• Do not use ACE inhibitors or ARBs as monotherapy in Black patients without heart failure or CKD—they are significantly less effective 1, 2, 6
• Do not underdose thiazide diuretics—hydrochlorothiazide 12.5 mg is insufficient; use 25-50 mg 2, 6
• Do not use beta-blockers as first-line therapy unless specific compelling indication exists (heart failure, post-MI) 7, 4
• Despite guidelines, many older Black adults continue to be initiated on non-recommended first-line agents, representing a significant quality gap 8